Table 3

Five-year cumulative risk and rate ratios of a hospitalized intracranial bleeding episode among 407 patients with cITP and 4069 members of the general population comparison cohort

Five-year risk among patients with cITP, % (95% CI)Five-year risk in the comparison cohort, % (95% CI)Crude 5-year RR (95% CI)Adjusted 5-year RR (95% CI)*
Total 1.4 (0.5-3.2) 0.6 (0.3-0.9) 2.8 (1.0-7.5) 3.2 (1.2-9.0) 
Age at cITP diagnosis, y     
    ≤ 60 0.4 (0.0-2.3) 0.1 (0.0-0.3) 5.1 (0.5-56.0) 5.0 (0.5-55.1) 
    > 60 2.6 (0.8-6.1) 1.1 (0.7-1.8) 2.7 (0.9-7.9) 3.0 (1.0-9.2) 
Sex     
    Female 1.9 (0.6-4.5) 0.3 (0.2-0.7) 6.0 (1.8-20.4) 12.3 (2.8-55.2) 
    Male 0.7 (0.1-3.3) 0.9 (0.5-1.8) 0.9 (0.1-6.9) 0.8 (0.1-6.3) 
Year of cITP diagnosis     
    1996-2001 1.2 (0.2-3.9) 0.3 (0.1-0.7) 4.2 (0.8-21.6) 9.2 (1.3-65.5) 
    2002-2007 1.7 (0.4-4.8) 0.8 (0.4-1.3) 2.3 (0.7-8.0) 2.2 (0.6-8.0) 
Comorbidity score     
    0 0.9 (0.2-3.2) 0.04 (0.0-0.3) 20.3 (1.8-223.7) 18.6 (1.7-205.7) 
    ≥ 1 2.3 (0.6-6.1) 1.4 (0.8-2.2) 1.9 (0.6-6.5) 2.1 (0.6-7.3) 
Five-year risk among patients with cITP, % (95% CI)Five-year risk in the comparison cohort, % (95% CI)Crude 5-year RR (95% CI)Adjusted 5-year RR (95% CI)*
Total 1.4 (0.5-3.2) 0.6 (0.3-0.9) 2.8 (1.0-7.5) 3.2 (1.2-9.0) 
Age at cITP diagnosis, y     
    ≤ 60 0.4 (0.0-2.3) 0.1 (0.0-0.3) 5.1 (0.5-56.0) 5.0 (0.5-55.1) 
    > 60 2.6 (0.8-6.1) 1.1 (0.7-1.8) 2.7 (0.9-7.9) 3.0 (1.0-9.2) 
Sex     
    Female 1.9 (0.6-4.5) 0.3 (0.2-0.7) 6.0 (1.8-20.4) 12.3 (2.8-55.2) 
    Male 0.7 (0.1-3.3) 0.9 (0.5-1.8) 0.9 (0.1-6.9) 0.8 (0.1-6.3) 
Year of cITP diagnosis     
    1996-2001 1.2 (0.2-3.9) 0.3 (0.1-0.7) 4.2 (0.8-21.6) 9.2 (1.3-65.5) 
    2002-2007 1.7 (0.4-4.8) 0.8 (0.4-1.3) 2.3 (0.7-8.0) 2.2 (0.6-8.0) 
Comorbidity score     
    0 0.9 (0.2-3.2) 0.04 (0.0-0.3) 20.3 (1.8-223.7) 18.6 (1.7-205.7) 
    ≥ 1 2.3 (0.6-6.1) 1.4 (0.8-2.2) 1.9 (0.6-6.5) 2.1 (0.6-7.3) 

cITP indicates chronic immune thrombocytopenia; CI, confidence interval; and RR, rate ratio.

*

Adjusted for age (≤ 60 y and > 60 y), sex, calendar year, and level of comorbidity.

Close Modal

or Create an Account

Close Modal
Close Modal